Qpex Biopharma has a total of 95 patents globally, out of which 34 have been granted. Of these 95 patents, more than 93% patents are active. The United States of America is where Qpex Biopharma has filed the maximum number of patents, followed by Europe. Parallelly, United States of America seems to be the main focused R&D centre and also is the origin country of Qpex Biopharma.
Qpex Biopharma was founded in 2018. Qpex works operates as a biotechnology company. The company is focused on creating novel antibiotics to counteract the increasing problem of antibiotic resistance around the world.
Do read about some of the most popular patents of Qpex Biopharma which have been covered by us in this article and also you can find Qpex Biopharma patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over Qpex Biopharma patent portfolio.
How many patents do the Founder and CEO of Qpex Biopharma have?
The Founder and CEO Michael Dudley have 0 patents.
How many patents does Qpex Biopharma have?
Qpex Biopharma has a total of 95 patents globally. These patents belong to 16 unique patent families. Out of 95 patents, 89 patents are active.
How Many Patents did Qpex Biopharma File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | Qpex Biopharma Applications Filed | Qpex Biopharma Patents Granted |
| 2023 | 1 | 8 |
| 2022 | 12 | 8 |
| 2021 | 19 | 7 |
| 2020 | 11 | 5 |
| 2019 | 10 | 3 |
| 2018 | 14 | 1 |
| 2017 | 19 | 1 |
| 2015 | 7 | 1 |
| 2014 | 2 | – |
How many Qpex Biopharma patents are Alive/Dead?
Worldwide Patents
How Many Patents did Qpex Biopharma File in Different Countries?
Countries in which Qpex Biopharma Filed Patents
| Country | Patent |
| United States Of America | 14 |
| Europe | 8 |
| Taiwan | 6 |
| China | 6 |
| Canada | 6 |
| Australia | 5 |
| Brazil | 5 |
| Hong Kong (S.A.R.) | 5 |
| India | 5 |
| Israel | 4 |
| Mexico | 4 |
| Germany | 2 |
| South Africa | 2 |
| Austria | 2 |
| Indonesia | 1 |
| Philippines | 1 |
| Spain | 1 |
| Poland | 1 |
| Saudi Arabia | 1 |
| Portugal | 1 |
| Macao | 1 |
| Singapore | 1 |
| Ukraine | 1 |
| Colombia | 1 |
| Denmark | 1 |
| Viet Nam | 1 |
| Malaysia | 1 |
| Chile | 1 |
| Norway | 1 |
Where are Research Centers of Qpex Biopharma Patents Located?
10 Best Qpex Biopharma Patents
US9132140B2 is the most popular patent in the Qpex Biopharma portfolio. It has received 28 citations so far from companies like Rempex Pharmaceuticals, Enanta Pharmaceuticals, VenatoRx Pharmaceuticals.
Below is the list of 10 most cited patents of Qpex Biopharma:
| Publication Number | Citation Count |
| US9132140B2 | 28 |
| US9642869B2 | 20 |
| US9963467B2 | 12 |
| US10206937B2 | 9 |
| WO2019075084A1 | 7 |
| US10294249B2 | 4 |
| US10662205B2 | 2 |
| US10618918B2 | 2 |
| US10570159B2 | 2 |
| CN111212843A | 2 |
What are Qpex Biopharma key innovation segments?
What Technologies are Covered by Qpex Biopharma?
The chart below distributes patents filed by Qpex Biopharma